Omvoh 100 mg/mL (Mirikizumab-Mrkz INJECTION, SOLUTION) 100 mg/mL

Omvoh 100 mg/mL is a subcutaneous injection solution containing mirikizumab-mrkz. This medication is used for managing specific inflammatory conditions. Learn more about its uses and effects.

Strength

100 mg/mL

Pack Size

2 SYRINGE in 1 CARTON (0002-8011-27) / 1 mL in 1 SYRINGE (0002-8011-01)

Manufacturer / TM Owner

Eli Lilly and Company

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Omvoh 100 mg/mL is primarily used for the treatment of moderate to severe plaque psoriasis. This medication works by targeting specific proteins involved in the inflammatory process, helping to reduce symptoms. People often ask, 'What is Omvoh used for?' It is designed to manage chronic inflammatory conditions where other treatments may not have been effective.

Side Effects

Common effects of Omvoh 100 mg/mL may include redness or itching at the injection site. Some individuals might experience fatigue or headaches. These effects vary and are not exhaustive. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Omvoh 100 mg/mL should be stored as directed to maintain its efficacy. It is important to follow proper handling instructions to avoid contamination. Individuals with known allergies to any of its components should avoid using this medication. Always consult a healthcare provider before starting any new treatment.

Avoid Interactions

Omvoh 100 mg/mL may interact with other medications, including those that affect the immune system. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect its efficacy.

Frequently Asked Questions

Omvoh 100 mg/mL is used for managing moderate to severe plaque psoriasis and other inflammatory conditions.

Omvoh 100 mg/mL is administered via subcutaneous injection. Follow the instructions provided by your healthcare provider.

Common side effects may include redness or itching at the injection site, fatigue, and headaches.

Omvoh 100 mg/mL may interact with other medications. Consult your healthcare provider for personalized advice.

Omvoh 100 mg/mL should be stored as directed to maintain its efficacy. Follow the storage instructions provided.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.